Nanobiotix S a (NBTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NBTX Annual Balance Sheets →
Quarterly balance sheet trends provide context on Nanobiotix S a's liquidity, leverage, and long-term financial structure.
Quarterly Report, GAAP in USD millions
ITEM
(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash And Cash Equivalents59.08
Cash & Short-term Investments59.00
Accounts receivable2.39
Other Current Assets8.81
Total Current Assets70.28
Equipment/Property/Plant Net5.11
Other Assets, Noncurrent0.50
Total Assets75.89
Liabilities
Other Liabilities, Current64.28
Current Provisions0.13
Total Current Liabilities64.41
Total Long-term Debt0.00
Noncurrent Provisions106.10
Total Liabilities170.51
Stockholders' Equity
Other Equity-94.62
Common Stockholder's Equity-94.62
Total Stockholder's Equity-94.62
Liabilities & Stockholder's Equity75.89
4 historic quarters locked

Sign in to unlock the full Nanobiotix S a balance sheet history.

About Nanobiotix S A Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: March 31, 2026
  • Source: nbx-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001760854-26-000003

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.